|
Atomistry » Chlorine » PDB 4aj2-4aqd » 4anq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 4aj2-4aqd » 4anq » |
Chlorine in PDB 4anq: Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with CrizotinibEnzymatic activity of Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
All present enzymatic activity of Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib:
2.7.10.1; Protein crystallography data
The structure of Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib, PDB code: 4anq
was solved by
M.Mctigue,
Y.Deng,
W.Liu,
A.Brooun,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4anq:
The structure of Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
(pdb code 4anq). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib, PDB code: 4anq: Jump to Chlorine binding site number: 1; 2; Chlorine binding site 1 out of 2 in 4anqGo back to![]() ![]()
Chlorine binding site 1 out
of 2 in the Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
![]() Mono view ![]() Stereo pair view
Chlorine binding site 2 out of 2 in 4anqGo back to![]() ![]()
Chlorine binding site 2 out
of 2 in the Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib
![]() Mono view ![]() Stereo pair view
Reference:
Q.Huang,
T.W.Johnson,
S.Bailey,
A.Brooun,
K.D.Bunker,
B.J.Burke,
M.R.Collins,
A.S.Cook,
J.J.Cui,
K.N.Dack,
J.G.Deal,
Y.Deng,
D.Dinh,
L.D.Engstrom,
M.He,
J.Hoffman,
R.L.Hoffman,
P.S.Johnson,
R.S.Kania,
H.Lam,
J.L.Lam,
P.T.Le,
Q.Li,
L.Lingardo,
W.Liu,
M.W.Lu,
M.Mctigue,
C.L.Palmer,
P.F.Richardson,
N.W.Sach,
H.Shen,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.Timofeevski,
K.Tsaparikos,
H.Wang,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.P.Edwards.
Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib. J.Med.Chem. V. 57 1170 2014.
Page generated: Sun Jul 21 09:15:12 2024
ISSN: ISSN 0022-2623 PubMed: 24432909 DOI: 10.1021/JM401805H |
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |